{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_182223.3:c.605G>A",
          "cDNA Change": {
            "transcript": "NM_182223.3",
            "ref": "G",
            "alt": "A",
            "position": "605"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "202"
          },
          "Description in input context": "c.605G>A (p.G202S)"
        },
        {
          "HGVS": "NM_182223.3:c.1445C>T",
          "cDNA Change": {
            "transcript": "NM_182223.3",
            "ref": "C",
            "alt": "T",
            "position": "1445"
          },
          "Protein Change": {
            "ref": "P",
            "alt": "L",
            "position": "482"
          },
          "Description in input context": "c.1445C>T (p.P482L)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005239"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using HEK293 cells transfected with LRRK2 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_182223.3:c.605G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased kinase activity observed in cells with the p.G202S variant."
        },
        {
          "Variant": "NM_182223.3:c.1445C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced kinase activity in cells with the p.P482L variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Two-way ANOVA with post-hoc Tukey's test was used."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 10% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity deviating by more than 25% from wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunoprecipitation",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Postmortem brain tissue from Parkinson's patients",
        "Description": "Immunoprecipitation was performed on brain tissue samples from Parkinson's patients and controls."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_182223.3:c.605G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "increased protein aggregation",
          "Result Description": "LRRK2 p.G202S showed enhanced aggregation in patient-derived tissue."
        },
        {
          "Variant": "NM_182223.3:c.1445C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "reduced protein stability",
          "Result Description": "LRRK2 p.P482L exhibited decreased protein levels in patient samples."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five brain tissue samples were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "No technical replicates were explicitly mentioned."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Control brain tissue from non-Parkinson's individuals was used."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "No negative control was explicitly described."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Unpaired t-test was used for comparison between groups."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein aggregation levels similar to controls.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein aggregation levels 2x higher than controls.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}